| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105520 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | US20110105519 Pharmaceutical Compositions for the Treatment of Sexual Disorders II |
| 05/05/2011 | US20110105518 Therapeutic agent for spinal canal stenosis |
| 05/05/2011 | US20110105517 Therapeutic agent for amyotrophic lateral sclerosis |
| 05/05/2011 | US20110105514 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105502 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105494 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | US20110105493 HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105492 ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105491 Thiazolidine compounds as orexin receptor antagonists |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105484 Filamin a-binding anti-inflammatory analgesic |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105469 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105468 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105467 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105465 Inhibitor of analgesic tolerance |
| 05/05/2011 | US20110105462 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105461 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105460 Triazole derivative or salt thereof |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105454 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105404 Beta Sheet Inhibiting Peptides For Preventing And/Or Treating Alzheimer`s Disease |
| 05/05/2011 | US20110105403 Peptides |
| 05/05/2011 | US20110105402 Silk Peptide For Improving Neuroprotective And Neurofunctional Effects And A Method Of Its Prepartion |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110105393 Methods for promoting stem cell proliferation and survival |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110105381 Prodrugs of Peripheral Phenolic Opioid Antagonists |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104301 Methods of reducing pain and inflammation |
| 05/05/2011 | US20110104281 Method for treating pain using a substituted 2-aminotetralin compound |
| 05/05/2011 | US20110104275 Methods and kits for treating cluster headache disorders |
| 05/05/2011 | US20110104245 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes |
| 05/05/2011 | US20110104244 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 05/05/2011 | US20110104236 Therapeutic compositions for treatment of ocular inflammatory disorders |
| 05/05/2011 | US20110104233 Flowable composition that sets to a substantially non-flowable state |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104214 Once-a-day oxycodone formulations |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104171 EphA4 Polypeptide Having a Novel Activity and Use Thereof |
| 05/05/2011 | US20110104165 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/05/2011 | US20110104153 Use of immunoregulatory nk cell populations for predicting the efficacy of anti-il-2r antibodies in multiple sclerosis patients |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104128 Device and Method for Transfecting Cells for Therapeutic Use |
| 05/05/2011 | US20110104125 Episomal reprogramming with chemicals |
| 05/05/2011 | US20110104123 Therapeutic protocol using stem cells in tissue and neuronal repair, maintenance, regeneration and augmentation |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104102 Method for stimulating mammalian cells and mammalian cell |
| 05/05/2011 | US20110104100 Compositions and methods of stem cell therapy for autism |
| 05/05/2011 | CA2779497A1 The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 05/05/2011 | CA2779496A1 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 05/05/2011 | CA2779177A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 05/05/2011 | CA2779124A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779120A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779107A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | CA2779097A1 Aryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779096A1 Methods for treating parkinson's disease |
| 05/05/2011 | CA2779095A1 Alkyl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779091A1 2-amino-9-[4-(4-methoxy-phenoxy)-piperidin-1-yl]-4-phenyl-indeno[1,2-d]pyrimidin-5-one and its use as a highly selective adenosine a2a receptor antagonist |
| 05/05/2011 | CA2779083A1 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 05/05/2011 | CA2779025A1 Therapeutic uses of oligomeric and polymeric monoterpenes |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2778979A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | CA2778949A1 Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2778678A1 Improved neurturin molecules |
| 05/05/2011 | CA2777827A1 Alleviating oxidative stress disorders with pufa derivatives |
| 05/05/2011 | CA2777632A1 Imidazole derivatives as casein kinase inhibitors |
| 05/05/2011 | CA2777532A1 Stable rasagiline composition |
| 05/05/2011 | CA2777033A1 Spirolactam derivatives and uses of same |
| 05/05/2011 | CA2742393A1 Dosing regimen associated with long-acting injectable paliperidone esters |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316849A2 Polypeptides comprising RER, derivatives and uses thereof |